ArticleVirchows Archiv : an international journal of pathology2025
Coccoid Helicobacter pylori in patients with obesity: an immunohistochemical study.
Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Optimized Amoxicillin Dosing is Associated with Higher Helicobacter pylori Eradication in Metabolic and Bariatric Surgery Candidates: A Retrospective Cohort Study.Obesity surgery · 2026Article
- The effect of obesity on the coccoid form transformation of Helicobacter pylori and its relationship with gastric inflammation pattern: a retrospective comparative study.Diagnostic pathology · 2026Article
- Phenotypic and Genotypic Characterization of Antimicrobial Resistance inInternational journal of microbiology · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Helicobacter pylori (HP) is a Gram-negative bacterium that infects approximately fifty percent (50%) of individuals worldwide. The coccoid form of HP, a dormant state with altered morphology, has been associated with persistent infections and antibiotic resistance. This study aimed to investigate the prevalence of the coccoid form of HP in patients living with obesity. Sleeve gastrectomy specimens from obese patients and gastric biopsies from non-obese individuals were analyzed. Immunohistochemistry (IHC) staining and histopathological examination were performed to identify and quantify the coccoid forms of HP. Statistical analysis was conducted to compare the results between the two groups. The study included 53 obese patients and 62 non-obese individuals. The percentage of coccoid forms of HP was significantly higher in obese patients compared to non-obese individuals (median 50% vs. 10%, p < 0.001). Type of gastritis was also significantly different between the groups. Obese patients exhibited a higher prevalence of the coccoid form of HP in their gastric mucosa. This finding suggests that the gastric microenvironment in obesity may favor the formation of the coccoid form, potentially impacting the colonization and pathogenicity of HP. The higher prevalence of the coccoid form in obese patients has important clinical implications, as it is more resistant to antibiotics and difficult to eradicate. Alternative treatment strategies may be necessary to effectively manage HP infections in this population. Furthermore, the presence of the coccoid form may increase the risk of HP-associated diseases in obese individuals. Further research is needed to elucidate the underlying mechanisms and explore novel treatment approaches for HP infection in the context of obesity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.